Javara has secured significant Series C funding to expand healthcare partnerships and therapeutic specialties. The investment comes from both existing and new community-based investors.
Javara has secured significant Series C funding to expand healthcare partnerships and therapeutic specialties. The investment comes from both existing and new community-based investors.
05/28/25, 2:10 PM
Location
Industry
healthcare
Round Type
series c
Investors
Community Based Investors
Javara, an integrated research organization, announced it secured Series C funding for growth. This investment will help expand current and new healthcare partnerships and grow in therapeutic areas like Oncology and Neurology. Founders express gratitude for the funding's role in driving the company's mission. The company aims to double patient access through localized clinical research collaborations.
Company Info
Location
winston-salem, north carolina, united states
Additional Info
Javara, the leading Integrated Research Organization (IRO), partners with large healthcare organizations to deliver clinical trial access at the point of care through integrated research staff and infrastructure. The company’s access to broad diverse patient populations through their trusted physician ensures clinical trials are completed with high enrollment and retention for quality data delivery. Javara’s centralized resources and standardized operations provide efficiencies for accelerated study start-up and quality outcomes, so fewer obstacles stand in the way of the product approval process. As pioneers of Clinical Research as a Care Option (CRAACO), Javara is transforming healthcare and changing lives by connecting the right patients to the right trials at the right time.